Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

ClinicalTrials.gov ID: NCT03097315

Public ClinicalTrials.gov record NCT03097315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis

Study identification

NCT ID
NCT03097315
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Clearside Biomedical, Inc.
Industry
Enrollment
38 participants

Conditions and interventions

Interventions

  • 4 mg CLS-TA Suprachoriodal Injection Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 3, 2017
Primary completion
Jan 23, 2018
Completion
Jan 23, 2018
Last update posted
Jun 22, 2021

2017 – 2018

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Retinal Consultants of Arizona Phoenix Arizona 85014
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
Northern California Retina Vitreous Associates Medical Group, Inc. Mountain View California 94040
Retina Group of Florida Fort Lauderdale Florida 33308
Marietta Eye Clinic Marietta Georgia 30060
Midwest Eye Retina Practicing at Midwest Eye Institute Indianapolis Indiana 46290
Ophthalmic Consultants of Boston Boston Massachusetts 02114
Texas Retina Associates Dallas Texas 75231
Retina Consultants of Houston Houston Texas 77030
Virginia Eye Consultants Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03097315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03097315 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →